Loading clinical trials...
Loading clinical trials...
Focal ExAblate™ MR-Guided Focused Ultrasound (MRgFUS) Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (OC-IRPC): Evaluation of Safety and Effectiveness
Conditions
Interventions
ExAblate MRgFUS
Locations
4
Canada
Toronto General Hospital
Toronto, Ontario, Canada
Beijing Hospital
Beijing, Beijing Municipality, China
Changhai Hospital of Shanghai
Shanghai, Shanghai Municipality, China
St. Mary's Hospital
London, United Kingdom
Start Date
June 1, 2016
Primary Completion Date
February 2, 2023
Completion Date
February 2, 2023
Last Updated
May 9, 2023
NCT06594926
NCT07177937
NCT06844383
NCT06926283
NCT06487507
NCT05919264
Lead Sponsor
InSightec
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions